Gufic BioSciences opened lower at ₹416.45, compared with its previous close of ₹418.55. During today's session, the stock has traded between ₹406.00 and ₹423.70, with an average traded price of ₹415.40. It is currently showing a downward intraday trend.
An investment of ₹10,000 made 5 years ago in Gufic BioSciences is now worth
₹ 20,865.00
giving a profit of
₹ 10,865.00 (108.65%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-6.05 (-1.45%)
Day High
₹423.70
Day Low
₹406.00
Day Open
₹416.45
Prev Close
₹418.55
Volume
87,401
Value Traded
₹3.63 Cr
1W Return
-1.72%
1M Return
-2.96%
3M Return
5.12%
6M Return
36.21%
1Y Return
12.97%
Market Cap (₹ Cr.)
4,137
PE Ratio
57.10
PB Ratio
6.30
Dividend Yield
0.02%
ROE
9.66%
ROCE
14.94%
Book Value (₹)
66.31
Face Value (₹)
1.00
EPS (TTM)
2.22
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-1.72%
6 Week
-
1 Month
-2.96%
3 Month
5.12%
9 Month
31.01%
Gufic BioSciences wins appeal against ₹4.33 crore tax demand
Gufic BioSciences won an appeal against a ₹4.33 crore income tax demand for AY 2024-25. The Commissioner of Income Tax (Appeals) passed the order on September 28, 2026. The demand arose from disallowance of expenditure under Section 143 of the Income Tax Act. The order results in the complete deletion of the ₹4.33 crore liability.
14 days agoGufic BioSciences receives CRISIL ESG rating of 62 for FY26
Gufic BioSciences received a CRISIL ESG rating of 62 (Strong) for FY26. The rating was assigned independently by Crisil based on public domain data. The company did not engage Crisil for this specific ESG assessment. Disclosure made under SEBI LODR Regulation 30(6) and related master circulars.
15 days agoGufic Biosciences to pay ₹1.72 lakh NSE penalty after waiver rejection
NSE rejected Gufic Biosciences' waiver application for a ₹1,72,000 penalty. Payment deadline set for October 3, 2026, following September 23, 2026 rejection. Non-compliance involved appointing a director over 75 without special resolution. BSE had previously rejected a similar waiver in March 2026.
19 days agoGufic Biosciences shareholders approve all AGM resolutions including dividend
Gufic Biosciences shareholders approved all five resolutions at its 42nd AGM held on September 4, 2026. A 10% final dividend of ₹0.10 per share was declared for FY26. Promoter group voted 100% in favor across all resolutions. Mr. Pranav J. Choksi re-appointed as director; Mr. Pankaj J. Gandhi continues as WTD beyond age 70. Total voting turnout was 79.94% with 43 shareholders participating.
1mo agoGufic Biosciences promotes Ami Shah, Pinak Padhya to senior roles
Ms. Ami Shah promoted to Head-Legal while retaining Company Secretary role. Mr. Pinak Padhya elevated to President – Sales & Marketing from Vice President. Changes effective September 2, 2026 following board approval. Disclosures made under Regulation 30 of SEBI Listing Regulations 2015.
1mo agoGufic BioSciences uploads Q1FY27 earnings call transcript
Gufic BioSciences uploaded the written transcript of its Q1FY27 earnings call. Revenue grew to ₹260.8 crore in Q1FY27, up from ₹226.9 crore in Q1FY26. EBITDA margin expanded to 18.09% from 14.6% year-on-year. Profit after tax increased to ₹22.46 crore, up from ₹12.1 crore. Filing submitted to BSE and NSE on August 21, 2026.
1mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 5 years ago in Gufic BioSciences is now worth
₹ 20,865.00
giving a profit of
₹ 10,865.00 (108.65%)
Note: Past profits do not guarantee future returns.
